Smith Group Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$5.65M Hold
24,958
0.3% 76
2021
Q4
$6.74M Hold
24,958
0.31% 72
2021
Q3
$6.04M Hold
24,958
0.31% 77
2021
Q2
$5.92M Sell
24,958
-3,353
-12% -$764K 0.29% 74
2021
Q1
$6.2M Buy
28,311
+4,181
+17% +$839K 0.33% 69
2020
Q4
$4.22M Sell
24,130
-13,246
-35% -$2.29M 0.24% 67
2020
Q3
$6.04M Sell
37,376
-128
-0.3% -$20.3K 0.32% 63
2020
Q2
$5.35M Buy
+37,504
New +$5.19M 0.3% 69
2016
Q1
Sell
-102,129
Closed -$10.8M 497
2015
Q4
$10.8M Buy
102,129
+30,077
+42% +$3.1M 0.32% 84
2015
Q3
$6.71M Sell
72,052
-10,941
-13% -$1.13M 0.26% 90
2015
Q2
$8.64M Buy
+82,993
New +$8.64M 0.29% 86

Other funds holding LH

Smith Group Asset Management's LH Position: Q1 2022 in Review

Smith Group Asset Management held its Labcorp (LH) position steady in Q1 2022 at 24,958 shares worth $5.65M. The position accounts for 0.3% of the portfolio, ranked #76.

Smith Group Asset Management first reported a position in LH in Q2 2015 and has held it in 11 quarters since. The position peaked at $10.8M in Q4 2015. 1,033 funds tracked by Wall St. Rank hold LH as of Q1 2022.

  • Smith Group Asset Management held 24,958 shares of Labcorp worth $5.65M as of Q1 2022.
  • Smith Group Asset Management left its Labcorp share count unchanged in Q1 2022.
  • Labcorp made up 0.3% of Smith Group Asset Management's portfolio in Q1 2022, its #76 holding.
  • Smith Group Asset Management first reported a position in Labcorp in Q2 2015 and has held it in 11 quarters since.
  • Smith Group Asset Management's Labcorp position peaked at $10.8M in Q4 2015.
  • 1,033 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on Smith Group Asset Management's 13F filing for Q1 2022, filed 5 May 2022.